Access cutting-edge t-cell acute lymphoblastic leukemia treatment through this clinical trial at a research site in St Louis. Study-provided care at no cost to qualified participants.
Access t-cell acute lymphoblastic leukemia specialists in St Louis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related t-cell acute lymphoblastic leukemia treatment provided free
The T-RRex study evaluates the efficacy of WU-CART-007 for patients with Relapsed/Refractory (R/R) T-Cell Acute Lymphoblastic Leukemia (T-ALL)/Lymphoblastic Lymphoma (LBL) and to WU-CART-007 as a therapy to induce complete Minimum Residual Disease (MRD) negative response
Sponsor: Wugen, Inc.
Check if you qualify for this t-cell acute lymphoblastic leukemia clinical trial in St Louis, MO
If you're searching for t-cell acute lymphoblastic leukemia treatment options in St Louis, MO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our St Louis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced t-cell acute lymphoblastic leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.